Search

Your search keyword '"Hellmut Samonigg"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Hellmut Samonigg" Remove constraint Author: "Hellmut Samonigg" Language english Remove constraint Language: english
38 results on '"Hellmut Samonigg"'

Search Results

1. TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients

2. Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.

Catalog

Books, media, physical & digital resources

3. Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature

4. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.

5. Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.

6. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.

7. Optimization of Diagnostic Elisa - Based Tests for the Detection of Auto-Antibodies Against Tumor Antigens in Human Serum

8. TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients

9. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

10. Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

11. A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options

12. A functional germline variant in GLI1 implicates Hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients

13. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients

14. Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients

15. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer

16. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

17. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients

18. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing

19. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients

20. The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy

21. Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival

22. Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

23. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis

24. Optimization of Diagnostic Elisa - Based Tests for the Detection of Auto-Antibodies Against Tumor Antigens in Human Serum

25. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer

26. Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation

27. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian “tumor of breast tissue: incidence, genetics, and environmental risk factors” study.

28. Resistance to Apoptosis and Expansion of Regulatory T Cells in Relation to the Detection of Circulating Tumor Cells in Patients with Metastatic Epithelial Cancer.

29. The Predictive Value of EGFR and HER-2/neu in Tumor Tissue and Serum for Response to Anthracycline-Based Neoadjuvant Chemotherapy of Breast Cancer.

30. A multigenic approach to predict breast cancer risk.

31. Global quality of life and its potential predictors in breast cancer patients: an exploratory study.

32. Implementation of a palliative care team in an Austrian university hospital.

34. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.

36. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.

37. Incidence of Anaemia in Breast Cancer Patients Receiving Adjuvant Chemotherapy.

38. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.